Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Gross Profit
Entera Bio Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Gross Profit
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Gross Profit
$9.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Gross Profit
$55.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Gross Profit
$1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Gross Profit
$73.4m
|
CAGR 3-Years
89%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Entera Bio Ltd's Gross Profit?
Gross Profit
0
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Gross Profit amounts to 0 USD.